Trans oral robotic surgery for oropharyngeal cancer: A multi institutional experience.

[1]  C. Crescio,et al.  Do We Have Enough Evidence to Specifically Recommend Transoral Robotic Surgery in HPV−Driven Oropharyngeal Cancer? A Systematic Review , 2023, Pathogens.

[2]  A. Laenen,et al.  Cervical squamous cell carcinoma of unknown primary: Oncological outcomes and prognostic factors , 2022, Frontiers in Oncology.

[3]  F. Bray,et al.  The Current Burden of Oropharyngeal Cancer: A Global Assessment Based on GLOBOCAN 2020. , 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  G. Meccariello,et al.  Lymph node metastasis in level IIb in oropharyngeal squamous cell carcinoma: a multicentric, longitudinal, retrospective analysis , 2022, European Archives of Oto-Rhino-Laryngology.

[5]  A. De Virgilio,et al.  Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus-Associated Oropharyngeal Cancer. , 2022, JAMA oncology.

[6]  K. Higgins,et al.  Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial. , 2022, JAMA oncology.

[7]  R. Simó,et al.  Reducing the unknowns: A systematic review & meta-analysis of the effectiveness of trans-oral surgical techniques in identifying head and neck primary cancer in carcinoma unknown primary. , 2022, Oral oncology.

[8]  T. Fenton,et al.  HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management , 2022, Nature Reviews Clinical Oncology.

[9]  P. Capaccio,et al.  Transoral robotic surgery for oropharyngeal cancer in the era of chemoradiation therapy. , 2022, Auris, nasus, larynx.

[10]  A. Laenen,et al.  Transoral robotic surgery (TORS) using the da Vinci Xi: prospective analysis of feasibility, safety, and outcomes , 2021, Head & neck.

[11]  P. Capaccio,et al.  Neck dissection and trans oral robotic surgery for oropharyngeal squamous cell carcinoma. , 2021, Auris, nasus, larynx.

[12]  G. Lawson,et al.  Anatomical‐based classification for transoral base of tongue resection , 2021, Head & neck.

[13]  A. De Virgilio,et al.  Transoral robotic surgery and intensity-modulated radiotherapy in the treatment of the oropharyngeal carcinoma: a systematic review and meta-analysis , 2020, European Archives of Oto-Rhino-Laryngology.

[14]  P. Capaccio,et al.  Trans oral robotic surgery versus definitive chemoradiotherapy for oropharyngeal cancer: 10-year institutional experience. , 2020, Oral oncology.

[15]  A. Del Mistro,et al.  Age-independent increasing prevalence of Human Papillomavirus-driven oropharyngeal carcinomas in North-East Italy , 2020, Scientific Reports.

[16]  E. Mendez,et al.  Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311). , 2020 .

[17]  G. Weinstein,et al.  A Phase II Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed Following Transoral Robotic Surgery for Human Papilloma Virus Related Squamous Cell Carcinoma of the Oropharynx. , 2019, International journal of radiation oncology, biology, physics.

[18]  M. Remacle,et al.  Anatomical-based classification for transoral lateral oropharyngectomy. , 2019, Oral oncology.

[19]  H. Shukla,et al.  Oncological outcome following initiation of treatment for stage III and IV HPV negative oropharyngeal cancers with transoral robotic surgery (TORS). , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  V. Grégoire,et al.  Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the “Best of” Trial , 2019, Front. Oncol..

[21]  K. Fung,et al.  Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. , 2019, The Lancet. Oncology.

[22]  E. Ofo,et al.  The emerging role of trans-oral robotic surgery for the detection of the primary tumour site in patients with head-neck unknown primary cancers: A meta-analysis. , 2019, Auris, nasus, larynx.

[23]  P. Golusiński,et al.  Role of palatine tonsillectomy in the diagnostic workup of head and neck squamous cell carcinoma of unknown primary origin: A systematic review and meta‐analysis , 2019, Head & neck.

[24]  Dylan F. Roden,et al.  Triple‐modality treatment in patients with advanced stage tonsil cancer , 2017, Cancer.

[25]  Young Min Park,et al.  A New Clinical Trial of Neoadjuvant Chemotherapy Combined With Transoral Robotic Surgery and Customized Adjuvant Therapy for Patients With T3 or T4 Oropharyngeal Cancer , 2017, Annals of Surgical Oncology.

[26]  R. Hermans,et al.  Up-front and Salvage Transoral Robotic Surgery for Head and Neck Cancer: A Belgian Multicenter Retrospective Case Series , 2017, Front. Oncol..

[27]  G. Weinstein,et al.  HPV‐related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery , 2016, Head & neck.

[28]  E. Genden,et al.  A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review , 2014, The Laryngoscope.

[29]  A. Garden,et al.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.